Abstract

Introduction Tim-3 is a Th1 lymphocytes membrane protein with inhibitory function. Its ligand, galectin-9, was recently identified and it is expressed in some lymphocyte subpopulation. In addition, endothelial cells and fibroblasts can also express galectin-9 according to the local cytokine milieu. Both molecules can act as important regulatory tools in the immune system. Aim Evaluate the expression of these immunoregulatory molecules inside kidney allografts during acute rejection episodes. Methods By using a quantitative polymerase chain reaction assay, we measured the levels of messenger RNA (mRNA) for galectin-9 and Tim-3 in 21 samples obtained at allograft nephrectomy. Five samples received the histological diagnosis of acute non-vascular rejection (ANVR), twelve of acute vascular rejection (AVR), and five of loss of non-immune cause (LNIC; as control). As cytolytic response markers we measured mRNA levels of granzyme B, interferon-γ and perforin. The statistic analysis was performed using one way analysis of variance (ANOVA) and Pearson correlation. Results The mean levels of Tim-3 mRNA expression were 13.99 ± 6.99 for LNIC, 48.13 ± 54.47 for RACNV and 238.63 ± 333.14 for RAV ( p = 0.004). For galectin-9, the mean values were 0.57 ± 0.49 for LNIC, 0.66 ± 0.36 for RACNV and 2.34 ± 1.62 for RAV ( p = 0.006). Furthermore, there was a positive correlation between both molecules ( r = 0.526, p = 0.016). Also, granzyme B, perforin and interferon-γ mRNA expression were different among the three groups. Conclusion Messenger RNA level expressions of all the studied molecules were higher inside allografts with more severe rejection. Moreover, there was a positive correlation between galectin-9 and Tim-3 mRNA levels. The simultaneous expression of galectin-9 and Tim-3 may indicate an immunoregulatory function, during the ongoing cytotoxic response.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.